These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 36301754)

  • 1. Establishment of a mouse model of Netherton syndrome based on CRISPR/Cas9 technology.
    Guo JZ; Su J; Dai H; Wang XY; Wu WB; Chen T; Zhang J; Wang WH
    Eur J Dermatol; 2022 Jul; 32(4):459-463. PubMed ID: 36301754
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A heterozygous null mutation combined with the G1258A polymorphism of SPINK5 causes impaired LEKTI function and abnormal expression of skin barrier proteins.
    Di WL; Hennekam RC; Callard RE; Harper JI
    Br J Dermatol; 2009 Aug; 161(2):404-12. PubMed ID: 19438860
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A proinflammatory role of KLK6 protease in Netherton syndrome.
    Zingkou E; Pampalakis G; Charla E; Nauroy P; Kiritsi D; Sotiropoulou G
    J Dermatol Sci; 2019 Jul; 95(1):28-35. PubMed ID: 31255470
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic activation of Nrf2 reduces cutaneous symptoms in a murine model of Netherton syndrome.
    Muzumdar S; Koch M; Hiebert H; Bapst A; Gravina A; Bloch W; Beer HD; Werner S; Schäfer M
    Dis Model Mech; 2020 Jun; 13(5):. PubMed ID: 32457102
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cathelicidin represents a new target for manipulation of skin inflammation in Netherton syndrome.
    Zingkou E; Pampalakis G; Sotiropoulou G
    Biochim Biophys Acta Mol Basis Dis; 2020 Oct; 1866(10):165831. PubMed ID: 32442469
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A novel SPINK5 donor splice site variant in a child with Netherton syndrome.
    Mintoff D; Borg I; Vornweg J; Mercieca L; Merdzanic R; Numrich J; Aquilina S; Pace NP; Fischer J
    Mol Genet Genomic Med; 2021 Mar; 9(3):e1611. PubMed ID: 33534181
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Netherton Syndrome: A Genotype-Phenotype Review.
    Sarri CA; Roussaki-Schulze A; Vasilopoulos Y; Zafiriou E; Patsatsi A; Stamatis C; Gidarokosta P; Sotiriadis D; Sarafidou T; Mamuris Z
    Mol Diagn Ther; 2017 Apr; 21(2):137-152. PubMed ID: 27905021
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Par2 inactivation inhibits early production of TSLP, but not cutaneous inflammation, in Netherton syndrome adult mouse model.
    Briot A; Lacroix M; Robin A; Steinhoff M; Deraison C; Hovnanian A
    J Invest Dermatol; 2010 Dec; 130(12):2736-42. PubMed ID: 20703245
    [TBL] [Abstract][Full Text] [Related]  

  • 9.
    Park NJ; Jo BG; Bong SK; Park SA; Lee S; Kim YK; Yang MH; Kim SN
    Int J Mol Sci; 2022 Aug; 23(15):. PubMed ID: 35955819
    [TBL] [Abstract][Full Text] [Related]  

  • 10. SPINK5 knockdown in organotypic human skin culture as a model system for Netherton syndrome: effect of genetic inhibition of serine proteases kallikrein 5 and kallikrein 7.
    Wang S; Olt S; Schoefmann N; Stuetz A; Winiski A; Wolff-Winiski B
    Exp Dermatol; 2014 Jul; 23(7):524-6. PubMed ID: 24848304
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Netherton Syndrome Caused by Heterozygous Frameshift Mutation Combined with Homozygous c.1258A>G Polymorphism in
    Moltrasio C; Romagnuolo M; Riva D; Colavito D; Ferrucci SM; Marzano AV; Tadini G; Brena M
    Genes (Basel); 2023 May; 14(5):. PubMed ID: 37239440
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A viable mouse model for Netherton syndrome based on mosaic inactivation of the Spink5 gene.
    Kasparek P; Ileninova Z; Haneckova R; Kanchev I; Jenickova I; Sedlacek R
    Biol Chem; 2016 Dec; 397(12):1287-1292. PubMed ID: 27543783
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Establishment of an induced pluripotent stem cell line (SAHGMUi001-A) from a patient with Netherton syndrome carrying SPINK5 mutation.
    Xu M; Wang L; Yin J; Xiong J; Guo Q; Yang W
    Stem Cell Res; 2021 Mar; 51():102213. PubMed ID: 33556917
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Novel SPINK5 Gene Mutation Associated with Netherton Syndrome in an Omani Patient.
    Hamza N; Al Sukaiti N; Ahmed KAM; Romano R; Gokhale UA; Pan-Hammarström Q
    Sultan Qaboos Univ Med J; 2021 Nov; 21(4):652-656. PubMed ID: 34888090
    [TBL] [Abstract][Full Text] [Related]  

  • 15. KLK5 Inactivation Reverses Cutaneous Hallmarks of Netherton Syndrome.
    Furio L; Pampalakis G; Michael IP; Nagy A; Sotiropoulou G; Hovnanian A
    PLoS Genet; 2015 Sep; 11(9):e1005389. PubMed ID: 26390218
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intrafamily and Interfamilial Phenotype Variation and Immature Immunity in Patients With Netherton Syndrome and Finnish SPINK5 Founder Mutation.
    Hannula-Jouppi K; Laasanen SL; Ilander M; Furio L; Tuomiranta M; Marttila R; Jeskanen L; Häyry V; Kanerva M; Kivirikko S; Tuomi ML; Heikkilä H; Mustjoki S; Hovnanian A; Ranki A
    JAMA Dermatol; 2016 Apr; 152(4):435-42. PubMed ID: 26865388
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Netherton syndrome: skin inflammation and allergy by loss of protease inhibition.
    Hovnanian A
    Cell Tissue Res; 2013 Feb; 351(2):289-300. PubMed ID: 23344365
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A synonymous mutation in SPINK5 exon 11 causes Netherton syndrome by altering exonic splicing regulatory elements.
    Fortugno P; Grosso F; Zambruno G; Pastore S; Faletra F; Castiglia D
    J Hum Genet; 2012 May; 57(5):311-5. PubMed ID: 22377713
    [TBL] [Abstract][Full Text] [Related]  

  • 19. rAAV2-mediated restoration of LEKTI in LEKTI-deficient cells from Netherton patients.
    Roedl D; Oji V; Buters JT; Behrendt H; Braun-Falco M
    J Dermatol Sci; 2011 Mar; 61(3):194-8. PubMed ID: 21251800
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Correlation between SPINK5 gene mutations and clinical manifestations in Netherton syndrome patients.
    Komatsu N; Saijoh K; Jayakumar A; Clayman GL; Tohyama M; Suga Y; Mizuno Y; Tsukamoto K; Taniuchi K; Takehara K; Diamandis EP
    J Invest Dermatol; 2008 May; 128(5):1148-59. PubMed ID: 17989726
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.